Expanded Access of Pemigatinib to Treat a Single Patient With Metastatic Pancreatic Cancer

Incyte

Status

Treatments: Drug: Pemigatinib

Study type: Expanded Access

Funder types: Other; Industry

Identifiers

NCT03906357

I-54828-20-08

Details and patient eligibility

About

Expanded access of Pemigatinib to treat a single patient with metastatic pancreatic cancer.

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria